MOLECULAR CHARACTERIZATION OF MICRORNA
INTERFERENCE AND ARISTOLOCHIC ACID
INTOXICATION FOUND IN UPPER TRACT UROTHELIAL
CARCINOMA IN PATIENTS WITH BALKAN ENDEMIC
NEPHROPATHY: A SYSTEMATIC REVIEW
OF THE CURRENT LITERATURE
Bašić D1*, Ignjatović I1, Janković Veličković Lj2, Veljković A3
*Corresponding Author: *Corresponding Authors: Dragoslav Bašić, Urology Clinic, University Clinical Center Niš, Faculty of
Medicine, University of Niš, Niš, Serbia, Puškinova 2, 18000 Niš, Serbia, Email: basicdr@gmail.com
page: 8
|
|
REFERENCES
1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki
TT, Bild DE. Prevalence of hypertrophic cardiomyopathy
in a general population of young adults:
Echocardiographic analysis of 4111 subjects in the
CARDIA study. Circulation. 1995; 92(4): 785-789.
2. Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H, et al.
Prevalence of idiopathic hypertrophic cardiomyopathy
in China: A population-based echocardiographic
analysis of 8080 adults. Am J Med. 2004; 116(1):
14-18.
3. Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB,
Epstein SE. Hypertrophic cardiomyopathy. Interrelations
of clinical manifestations, pathophysiology, and
therapy (2). N Engl J Med. 1987; 316(14): 844-852.
4. Wigle ED, Rakowski H, Kimball BP, Williams WG.
Hypertrophic cardiomyopathy. Clinical spectrum and
treatment. Circulation. 1995; 92(7): 1680-1692.
5. Spirito P, Seidman CE, McKenna WJ, Maron BJ.
The management of hypertrophic cardiomyopathy.
N Engl J Med. 1997; 336(11): 775-785.
6. Richard P, Charron P, Carrier L, Ledeuil C, Cheav
T, Pichereau C, et al. Hypertrophic cardiomyopathy:
distribution of disease genes, spectrum of mutations,
and implications for a molecular diagnosis strategy.
Circulation. 2003; 107(17): 2227-2232.
7. Merante F, Myint T, Tein I, Benson L, Robinson BH.
An additional mitochondrial tRNA (Ile) point mutation
(A-to-G at nucleotide 4295) causing hypertrophic
cardiomyopathy. Hum Mutat. 1996; 8(3): 216-222.
8. Arad M, Benson DW, Perez-Atayde AR, McKenna
WJ, Sparks EA, Kanter RJ, et al. Constitutively active
AMP kinase mutations cause glycogen storage
disease mimicking hypertrophic cardiomyopathy. J
Clin Invest 2002; 109(3): 357-362.
9. Seidman JG, Seidman C. Transcription factor haploinsufficiency:
when half a loaf is not enough. J Clin
Invest 2002; 109(4): 451-455.
10. Charron P, Dubourg O, Desnos M, Bennaceur M,
Carrier L, Camproux AC, et al. Clinical features and
prognostic implications of familial hypertrophic cardiomyopathy
related to the cardiac myosin-binding
protein C gene. Circulation 1998; 97(22): 2230-2236.
11. Charron P, Dubourg O, Desnos M, Isnard R, Hagege
A, Bonne G, et al. Genotype-phenotype correlations
in familial hypertrophic cardiomyopathy. A comparison
between mutations in the cardiac protein-C and
the beta-myosin heavy chain genes. Eur Heart J. 1998;
19(1): 139-145.
12. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins
H, Chudley AE, McKenna W, et al. Mutations in the
gene for cardiac myosin-binding protein C and lateonset
familial hypertrophic cardiomyopathy. N Engl
J Med 1998; 338(18): 1248-1257.
13. Biagini E, Olivotto I, Iascone M, Parodi MI, Girolami
F, Frisso G, et al. Significance of sarcomere gene
mutations analysis in the end-stage phase of hypertrophic
cardiomyopathy. Am J Cardiol. 2014; 114(5):
769-776.
14. Rodríguez-García MI, Monserrat L, Ortiz M, Fernández
X, Cazón L, Núñez L, et al. Screening mutations
in myosin binding protein C3 gene in a cohort of
patients with Hypertrophic Cardiomyopathy. BMC
Med Genet. 2010; 11: 67.
15. Marsiglia JD, Credidio FL, de Oliveira TG, Reis RF,
Antunes Mde O, de Araujo AQ, et al. Screening of
MYH7, MYBPC3, and TNNT2 genes in Brazilian
patients with hypertrophic cardiomyopathy. Am Heart
J. 2013; 166(4): 775-782.
16. Liu X, Jiang T, Piao C, Li X, Guo J, Zheng S, et al.
Screening Mutations of MYBPC3 in 114 Unrelated
Patients with Hypertrophic Cardiomyopathy by Targeted
Capture and Next-generation Sequencing. Sci
Rep. 2015; 5: 11411.
17. Emrahi L, Tabrizi MT, Gharehsouran J, et al. Spectrum
of MYBPC3 Gene Mutations in Patients with
Hypertrophic Cardiomyopathy, Reporting Two Novel
Mutations from North-West of Iran. Clin Lab. 2016;
62(5): 757-764.
18. Maron BJ, Maron MS, Semsarian C. Double or compound
sarcomere mutations in hypertrophic cardiomyopathy:
a potential link to sudden death in the absence of conventional risk factors. Heart Rhythm.
2012; 9(1): 57-63.
19. Marziliano N, Merlini PA, Vignati G, Orsini F, Motta
V, Bandiera L, et al. A case of compound mutations
in the MYBPC3 gene associated with biventricular
hypertrophy and neonatal death. Neonatology. 2012;
102(4): 254-258.
20. Schaefer E, Helms P, Marcellin L, Desprez P, Billaud
P, Chanavat V, et al. Next-generation sequencing
(NGS) as a fast molecular diagnosis tool for left ventricular
noncompaction in an infant with compound
mutations in the MYBPC3 gene. Eur J Med Genet.
2014; 57(4): 129-132.
21. Wessels MW, Herkert JC, Frohn-Mulder IM, Dalinghaus
M, van den Wijngaard A, de Krijger RR, et al.
Compound heterozygous or homozygous truncating
MYBPC3 mutations cause lethal cardiomyopathy
with features of noncompaction and septal defects.
Eur J Hum Genet. 2015; 23(7): 922-928.
22. Driest SLV, Vasile VC, Ommen SR, Will ML, Tajik
AJ, Gersh BJ, et al. Myosin binding protein C mutations
and compound heterozygosity in hypertrophic
cardiomyopathy. J Am Coll Cardiol. 2004; 44(9):
1903-1310.
23. Erdmann J, Daehmlow S, Wischke S, Senyuva M,
Werner U, Raible J, et al. Mutation spectrum in a
large cohort of unrelated consecutive patients with
hypertrophic cardiomyopathy. Clin Genet. 2003;
64(4): 339-349.
24. Zhang R, Chen S, Han P, Chen F, Kuang S, Meng Z,
et al. Whole exome sequencing identified a homozygous
novel variant in CEP290 gene causes Meckel
syndrome. J Cell Mol Med. 2020; 24(2): 1906-1916.
25. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-
Foster J, et al. Standards and guidelines for the interpretation
of sequence variants: a joint consensus
recommendation of the American College of Medical
Genetics and Genomics and the Association for Molecular
Pathology. Genet Med. 2015; 17(5): 405-424.
26. Schwarz JM, Cooper DN, Schuelke M, Seelow D.
MutationTaster2: mutation prediction for the deepsequencing
age. Nat Methods. 2014; 11(4): 361-362.
27. Marian AJ. On genetic and phenotypic variability of
hypertrophic cardiomyopathy: nature versus nurture.
J Am Coll Cardiol. 2001; 38(2): 331-334.
28. Watkins H, Conner D, Thierfelder L, Jarcho JA, Mac-
Rae C, McKenna WJ, et al. Mutations in the cardiac
myosin binding protein-C gene on chromosome 11
cause familial hypertrophic cardiomyopathy. Nat
Genet. 1995; 11(4): 434-437.
29. Gómez J, Reguero JR, Morís C, Martín M, Alvarez
V, Alonso B, et al. Mutation analysis of the main
hypertrophic cardiomyopathy genes using multiplex
amplification and semiconductor next-generation sequencing.
Circ J. 2014; 78(12): 2963-2971.
30. Loar RW, Bos JM, Will ML, Ommen SR, Ackerman
MJ. Genotype-phenotype Correlations of Hypertrophic
Cardiomyopathy When Diagnosed in Children,
Adolescents, and Young Adults. Congenital Heart
Disease. 2015; 10(6): 529-536.
31. Maron BJ. Hypertrophic cardiomyopathy: an important
global disease. Am J Med. 2004; 116(1): 63-65.
32. Maron BJ. Hypertrophic cardiomyopathy: a systematic
review. JAMA 2002; 287(10): 1308-1320.
33. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer
MA, Link MS, et al. 2011 ACCF/AHA guideline for
the diagnosis and treatment of hypertrophic cardiomyopathy:
executive summary: a report of the American
College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol 2011; 58(25): 2703-2738.
34. Marian AJ, Braunwald E. Hypertrophic cardiomyopathy:
genetics, pathogenesis, clinical manifestations,
diagnosis, and therapy. Circ Res. 2017; 121(7): 749-
770.
35. Wijnker PJM, Friedrich FW, Dutsch A, Reischmann
S, Eder A, Mannhardt I, et al. Comparison of the
effects of a truncating and a missense MYBPC3 mutation
on contractile parameters of engineered heart
tissue. J Mol Cell Cardiol. 2016; 97: 82-92.
36. Helms AS, Davis FM, Coleman D, Bartolone SN,
Glazier AA, Pagani F, et al. Sarcomere mutation
specific expression patterns in human hypertrophic
cardiomyopathy. Circ Cardiovasc Genet. 2014; 7(4):
434-443.
37. Mohamed IA, Krishnamoorthy NT, Nasrallah GK,
Da’as SI. The role of cardiac myosin binding protein
C3 in hypertrophic cardiomyopathy progress and
novel therapeutic opportunities. J Cell Physiol 2017;
232(7): 1650-1659.
38. Dai Y, Liang S, Dong X, Zhao Y, Ren H, Guan Y, et
al. Whole exome sequencing identified a novel DAG1
mutation in a patient with rare, mild and late age of
onset muscular dystrophy-dystroglycanopathy. J Cell
Mol Med. 2019; 23(2): 811-818.
39. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor
HK, Dent KM, et al. Exome sequencing identifies
the cause of a mendelian disorder. Nat Genet. 2010;
42(1): 30-35.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
